Last Price
0.83
Today's Change
+0.052 (6.68%)
Day's Change
0.771 - 0.896
Trading Volume
1,637,452
Market Cap
15 Million
Shares Outstanding
18 Million
Avg Volume
8,191,831
Avg Price (50 Days)
0.45
Avg Price (200 Days)
0.42
PE Ratio
-2.52
EPS
-0.33
Earnings Announcement
10-Apr-2025
Previous Close
0.78
Open
0.78
Day's Range
0.7707 - 0.8962
Year Range
0.24 - 1.35
Trading Volume
1,675,057
1 Day Change
6.72%
5 Day Change
10.67%
1 Month Change
29.69%
3 Month Change
137.75%
6 Month Change
165.09%
Ytd Change
173.93%
1 Year Change
-18.63%
3 Year Change
-81.09%
5 Year Change
-70.46%
10 Year Change
-9.78%
Max Change
-84.19%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Devices
Description:
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.